 Marlena Wosiski-Kuhn
Concepts (130)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Amyotrophic Lateral Sclerosis | 6 | 2021 | 96 | 2.180 |
Why?
| | Neuronal Plasticity | 5 | 2014 | 302 | 1.120 |
Why?
| | Hippocampus | 6 | 2018 | 929 | 0.980 |
Why?
| | Interleukin-6 | 2 | 2020 | 785 | 0.950 |
Why?
| | Brain-Derived Neurotrophic Factor | 2 | 2018 | 140 | 0.940 |
Why?
| | Receptors, Interleukin-6 | 2 | 2020 | 46 | 0.790 |
Why?
| | Immunity | 2 | 2018 | 141 | 0.690 |
Why?
| | Diabetes Mellitus, Experimental | 2 | 2018 | 198 | 0.640 |
Why?
| | Immunomodulation | 1 | 2018 | 99 | 0.550 |
Why?
| | Pituitary-Adrenal System | 1 | 2018 | 171 | 0.530 |
Why?
| | Stress, Psychological | 2 | 2018 | 1124 | 0.520 |
Why?
| | Hypothalamo-Hypophyseal System | 1 | 2018 | 206 | 0.520 |
Why?
| | Brain Mapping | 1 | 2018 | 523 | 0.470 |
Why?
| | Disease Progression | 2 | 2020 | 2752 | 0.460 |
Why?
| | Nerve Net | 2 | 2013 | 268 | 0.390 |
Why?
| | Cell Adhesion Molecules, Neuronal | 1 | 2013 | 41 | 0.390 |
Why?
| | Receptors, Glucocorticoid | 1 | 2014 | 138 | 0.380 |
Why?
| | Serine Endopeptidases | 1 | 2013 | 119 | 0.370 |
Why?
| | Dentate Gyrus | 1 | 2012 | 39 | 0.370 |
Why?
| | Extracellular Matrix Proteins | 1 | 2013 | 157 | 0.360 |
Why?
| | Dendritic Spines | 1 | 2012 | 68 | 0.350 |
Why?
| | Longevity | 1 | 2011 | 174 | 0.320 |
Why?
| | Long-Term Potentiation | 1 | 2012 | 199 | 0.320 |
Why?
| | Nerve Tissue Proteins | 1 | 2013 | 602 | 0.300 |
Why?
| | Stress, Physiological | 1 | 2011 | 450 | 0.280 |
Why?
| | Aging | 2 | 2013 | 1857 | 0.220 |
Why?
| | Mice, Inbred C57BL | 8 | 2018 | 5801 | 0.220 |
Why?
| | Animals | 13 | 2018 | 37243 | 0.180 |
Why?
| | Glucocorticoids | 2 | 2017 | 528 | 0.180 |
Why?
| | Receptors, Leptin | 2 | 2017 | 25 | 0.170 |
Why?
| | Synapses | 2 | 2014 | 426 | 0.150 |
Why?
| | Genes, Immediate-Early | 1 | 2018 | 25 | 0.150 |
Why?
| | C-Reactive Protein | 1 | 2021 | 411 | 0.150 |
Why?
| | Genes, fos | 1 | 2018 | 37 | 0.150 |
Why?
| | Septal Nuclei | 1 | 2018 | 24 | 0.150 |
Why?
| | Models, Animal | 2 | 2018 | 396 | 0.150 |
Why?
| | Neuromuscular Junction | 1 | 2018 | 63 | 0.140 |
Why?
| | Feedback, Physiological | 1 | 2018 | 81 | 0.140 |
Why?
| | Mice | 8 | 2018 | 17828 | 0.140 |
Why?
| | Athletic Injuries | 1 | 2024 | 515 | 0.140 |
Why?
| | Anti-Inflammatory Agents | 1 | 2021 | 475 | 0.140 |
Why?
| | Corticosterone | 1 | 2018 | 242 | 0.140 |
Why?
| | Metyrapone | 2 | 2014 | 5 | 0.130 |
Why?
| | Physical Conditioning, Animal | 2 | 2017 | 254 | 0.130 |
Why?
| | Glycogen Synthase Kinase 3 beta | 1 | 2017 | 73 | 0.130 |
Why?
| | Vibration | 1 | 2017 | 75 | 0.130 |
Why?
| | Brain Concussion | 1 | 2024 | 576 | 0.130 |
Why?
| | tau Proteins | 1 | 2017 | 93 | 0.120 |
Why?
| | Analysis of Variance | 1 | 2018 | 1317 | 0.120 |
Why?
| | Antibodies, Monoclonal, Humanized | 1 | 2021 | 814 | 0.120 |
Why?
| | Memory | 1 | 2017 | 258 | 0.120 |
Why?
| | Behavior, Animal | 1 | 2018 | 512 | 0.110 |
Why?
| | Ultrasonography | 1 | 2018 | 748 | 0.110 |
Why?
| | Steroid 11-beta-Hydroxylase | 1 | 2014 | 2 | 0.110 |
Why?
| | Mice, Obese | 1 | 2014 | 67 | 0.110 |
Why?
| | Cohort Studies | 2 | 2024 | 5744 | 0.100 |
Why?
| | Cytokines | 1 | 2021 | 2083 | 0.100 |
Why?
| | Longitudinal Studies | 1 | 2020 | 2850 | 0.100 |
Why?
| | Male | 10 | 2024 | 68250 | 0.100 |
Why?
| | Neurons | 2 | 2012 | 1602 | 0.100 |
Why?
| | Receptors, Pituitary Hormone | 1 | 2012 | 1 | 0.100 |
Why?
| | Phosphorylation | 1 | 2017 | 1767 | 0.100 |
Why?
| | Biomarkers | 2 | 2021 | 4095 | 0.100 |
Why?
| | Temporal Lobe | 1 | 2013 | 102 | 0.090 |
Why?
| | Interleukin-1beta | 1 | 2014 | 378 | 0.090 |
Why?
| | Case-Control Studies | 1 | 2019 | 3574 | 0.090 |
Why?
| | Conditioning, Classical | 1 | 2012 | 107 | 0.090 |
Why?
| | Microglia | 1 | 2014 | 256 | 0.090 |
Why?
| | Anxiety | 1 | 2018 | 1070 | 0.090 |
Why?
| | Energy Metabolism | 1 | 2017 | 927 | 0.090 |
Why?
| | Humans | 9 | 2024 | 138972 | 0.080 |
Why?
| | Obesity | 2 | 2014 | 2994 | 0.080 |
Why?
| | Enzyme Inhibitors | 1 | 2014 | 850 | 0.080 |
Why?
| | Drinking Behavior | 1 | 2009 | 13 | 0.080 |
Why?
| | Neurogenesis | 1 | 2011 | 153 | 0.080 |
Why?
| | Reward | 1 | 2012 | 251 | 0.080 |
Why?
| | Appetite Regulation | 1 | 2009 | 32 | 0.080 |
Why?
| | Glucans | 1 | 2009 | 27 | 0.080 |
Why?
| | Dietary Sucrose | 1 | 2009 | 49 | 0.080 |
Why?
| | Muscle, Skeletal | 1 | 2018 | 1734 | 0.070 |
Why?
| | Learning | 1 | 2012 | 422 | 0.070 |
Why?
| | Taste | 1 | 2009 | 230 | 0.070 |
Why?
| | Inflammation | 1 | 2018 | 2853 | 0.070 |
Why?
| | Disease Models, Animal | 2 | 2017 | 4316 | 0.070 |
Why?
| | Alzheimer Disease | 1 | 2013 | 569 | 0.060 |
Why?
| | Middle Aged | 4 | 2024 | 33782 | 0.060 |
Why?
| | Diabetes Mellitus, Type 2 | 2 | 2017 | 2516 | 0.060 |
Why?
| | Aged | 3 | 2021 | 24172 | 0.060 |
Why?
| | Adult | 4 | 2024 | 38393 | 0.060 |
Why?
| | Diabetes Mellitus | 1 | 2014 | 1068 | 0.060 |
Why?
| | Glasgow Coma Scale | 1 | 2024 | 200 | 0.050 |
Why?
| | Post-Concussion Syndrome | 1 | 2024 | 178 | 0.040 |
Why?
| | Young Adult | 3 | 2024 | 13371 | 0.040 |
Why?
| | Female | 4 | 2024 | 74016 | 0.040 |
Why?
| | Diaphragm | 1 | 2018 | 43 | 0.040 |
Why?
| | Vital Capacity | 1 | 2018 | 312 | 0.030 |
Why?
| | Infusions, Intraventricular | 1 | 2017 | 4 | 0.030 |
Why?
| | Thiadiazoles | 1 | 2017 | 23 | 0.030 |
Why?
| | Muscular Atrophy | 1 | 2017 | 86 | 0.030 |
Why?
| | Double-Blind Method | 1 | 2021 | 1949 | 0.030 |
Why?
| | Adipocytes | 1 | 2017 | 227 | 0.030 |
Why?
| | Organ Culture Techniques | 1 | 2014 | 157 | 0.030 |
Why?
| | Adolescent | 2 | 2024 | 21581 | 0.030 |
Why?
| | Pilot Projects | 1 | 2018 | 1765 | 0.020 |
Why?
| | Fluorescent Antibody Technique | 1 | 2014 | 386 | 0.020 |
Why?
| | Patch-Clamp Techniques | 1 | 2014 | 291 | 0.020 |
Why?
| | Body Weight | 1 | 2017 | 996 | 0.020 |
Why?
| | Mice, Mutant Strains | 1 | 2012 | 309 | 0.020 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 1 | 2014 | 850 | 0.020 |
Why?
| | Surveys and Questionnaires | 1 | 2024 | 5884 | 0.020 |
Why?
| | Blotting, Western | 1 | 2014 | 1232 | 0.020 |
Why?
| | Inflammation Mediators | 1 | 2014 | 513 | 0.020 |
Why?
| | Gene Deletion | 1 | 2012 | 389 | 0.020 |
Why?
| | Oligopeptides | 1 | 2012 | 266 | 0.020 |
Why?
| | Mice, Knockout | 1 | 2017 | 3029 | 0.020 |
Why?
| | Observation | 1 | 2009 | 57 | 0.020 |
Why?
| | Immunohistochemistry | 1 | 2014 | 1730 | 0.020 |
Why?
| | Tongue | 1 | 2009 | 82 | 0.020 |
Why?
| | Sweetening Agents | 1 | 2009 | 55 | 0.020 |
Why?
| | Follow-Up Studies | 1 | 2018 | 5152 | 0.020 |
Why?
| | Insulin Resistance | 1 | 2017 | 1222 | 0.020 |
Why?
| | Mice, Transgenic | 1 | 2014 | 2171 | 0.020 |
Why?
| | Energy Intake | 1 | 2009 | 506 | 0.020 |
Why?
| | Aged, 80 and over | 1 | 2018 | 7685 | 0.020 |
Why?
| | Treatment Outcome | 1 | 2021 | 10921 | 0.020 |
Why?
| | Water | 1 | 2009 | 461 | 0.020 |
Why?
| | Retrospective Studies | 1 | 2024 | 15901 | 0.020 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2009 | 2047 | 0.010 |
Why?
| | Feeding Behavior | 1 | 2009 | 685 | 0.010 |
Why?
| | Time Factors | 1 | 2009 | 6869 | 0.010 |
Why?
|
|
Wosiski-Kuhn's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|